Nonpalpable pulmonary lesions
Conditions
Interventions
The evaluation of new method of ultrathin bronchoscope guided preoperative marking with indigo carmine, ICG and computed tomography contrast agents for the lesions with right upper lobe/left upper seg
Sponsors
Toyofumi Yoshikawa
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with lesions in which pulmonary lung cancer or metastatic lung cancer is suspected or diagnosed requireing resection lines other than the typical interlobar fissure (2) Patients with lesions requiring preoperative marking in the lesions located on the right upper lobe, left upper segment, and S6 (3) 18 years old or older (4) The informed consent
Exclusion criteria
Exclusion criteria: (1) Allergy to xylocaine, indigo carmine or indocyanine green (ICG) (2) Allergy to iodine (3) Severe thyroid disease (4) Severe bleeding tendency (5) Women who are pregnant or may become pregnant (6) Other clinical difficulties in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of overal detectable marking with indigo carmine or ICG | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Consistency rate of overall detectable marking based on preprocedural and postprocedural computed tomography (2) Marking grade based on the visible marking of each indigo carmine or ICG. (3) Succsss rate of overal detactable mariking based on the degree of the emphysema on chest computed tomography (4) Safety | — |
Contacts
Public ContactIto Takayasu
Nagoya University Hospital
Outcome results
None listed